Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of tumor markers, preventing damage to healthy tissue. The system can also deliver multiple drugs at once, potentially overcoming resistance. This marks a step toward medicines that behave more like smart, responsive machines inside the body.
source https://www.sciencedaily.com/releases/2026/04/260402042744.htm
Inside the competition for capital at some of the world's biggest banks
-
As the U.S. economy becomes more consolidated, the strategic decisions of
senior leaders at leading companies carry ever-greater weight. A lot is
riding on...
1 day ago
No comments:
Post a Comment